| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $30,095 | 4 | 100 |
Sells | $0 | 0 | 0 |
| DOW GEOFFREY S | President and CEO | 4 | $30,095 | 0 | $0 | $30,095 |
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis. Its pipeline includes several investigational drugs: Tafenoquine, in its 'Arakoda regimen' formulation, is undergoing Phase IIb clinical trials for potential use against COVID-19. Additionally, Tafenoquine is the subject of Phase IIA clinical studies for …
Over the last 12 months, insiders at 60 Degrees Pharmaceuticals, Inc. have bought $30,095 and sold $0 worth of 60 Degrees Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at 60 Degrees Pharmaceuticals, Inc. have bought $56,843 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DOW GEOFFREY S (President and CEO) — $30,095.
The last purchase of 7,350 shares for transaction amount of $10,131 was made by DOW GEOFFREY S (President and CEO) on 2026‑06‑12.
| 2026-06-12 | DOW GEOFFREY S | President and CEO | 7,350 0.9236% | $1.38 | $10,131 | -16.91% | ||
| 2025-12-15 | DOW GEOFFREY S | President and CEO | 9,670 0.2933% | $0.80 | $7,759 | -52.74% | ||
| 2025-12-11 | DOW GEOFFREY S | President and CEO | 3,613 0.1177% | $0.92 | $3,318 | -55.57% | ||
| 2025-12-10 | DOW GEOFFREY S | President and CEO | 9,350 0.2849% | $0.95 | $8,886 | -58.51% | ||
| 2025-06-03 | XU CHERYL | director | 5,000 0.3362% | $2.88 | $14,410 | -64.35% | ||
| 2024-12-16 | XU CHERYL | director | 2,000 0.0839% | $1.45 | $2,900 | -75.50% | ||
| 2024-12-13 | XU CHERYL | director | 6,000 0.2885% | $1.56 | $9,375 | -73.62% | ||
| 2024-12-12 | XU CHERYL | director | 5,000 0.2453% | $1.82 | $9,125 | -77.33% | ||
| 2024-12-09 | DOW GEOFFREY S | President and CEO | 35,823 1.437% | $1.27 | $45,563 | -74.00% | ||
| 2024-12-06 | DOW GEOFFREY S | President and CEO | 20,579 0.8725% | $1.20 | $24,672 | -67.13% | ||
| 2024-12-05 | DOW GEOFFREY S | President and CEO | 17,549 0.7539% | $1.11 | $19,520 | -68.24% | ||
| 2024-11-21 | DOW GEOFFREY S | President and CEO | 3,500 0.1312% | $0.91 | $3,195 | -52.63% | ||
| 2024-11-20 | DOW GEOFFREY S | President and CEO | 1,000 0.038% | $0.92 | $924 | -54.46% | ||
| 2024-11-19 | DOW GEOFFREY S | President and CEO | 2,500 0.0923% | $0.90 | $2,248 | -53.59% | ||
| 2024-08-27 | XU CHERYL | director | 5,000 0.349% | $1.70 | $8,500 | -65.18% |
| DOW GEOFFREY S | President and CEO | 24131 0.6861% | $24,372.31 | 10 | 0 | <0.0001% |
| XU CHERYL | director | 15816 0.4497% | $15,974.16 | 5 | 0 | <0.0001% |
$6,974,678 | 45 | -14.98% | $4.63M | |
$633,070 | 27 | -5.89% | $2.04M | |
$8,249,886 | 17 | -47.87% | $399,787.00 | |
$117,515 | 16 | -27.38% | $1.66M | |
$439,090 | 12 | 8.72% | $486,870.00 |
| Increased Positions | 3 | +37.5% | 6,791 | +63.77% |
| Decreased Positions | 2 | -25% | 6,350 | -59.63% |
| New Positions | 2 | New | 5,891 | New |
| Sold Out Positions | 2 | Sold Out | 6,350 | Sold Out |
| Total Postitions | 9 | +12.5% | 11,090 | +4.14% |
| Drw Securities, Llc | $13.00 | 0.63% | 25,211 | +25,211 | New | 2025-09-30 |
| Geode Capital Management, Llc | $6.00 | 0.31% | 12,449 | -67 | -0.54% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $2.00 | 0.08% | 3,140 | +542 | +20.86% | 2025-09-30 |
| Ubs Group Ag | $1.00 | 0.04% | 1,476 | +1,462 | +10,442.86% | 2025-09-30 |
| Citigroup Inc | $0 | 0.01% | 189 | +189 | New | 2025-09-30 |
| Osaic Holdings, Inc. | $0 | <0.01% | 100 | 0 | 0% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 30 | +17 | +130.77% | 2025-09-30 |
| Safe Harbor Fiduciary, Llc | $0 | 0% | 0 | -275 | Sold Out | 2025-06-30 |